한국임상약학회지 (Korean Journal of Clinical Pharmacy)
- 제13권2호
- /
- Pages.59-66
- /
- 2003
- /
- 1226-6051(pISSN)
- /
- 2508-786X(eISSN)
항암화학요법을 받은 유방암환자에서의 Filgrastim사용 현황
The Patterns of Filgrastim Uses in Breast Cancer Patients Receiving Chemotherapy
- Jung, Hye Jin (Graduate School of Clinical Health Sciences, Ewha Womans University) ;
- Shin, Wan Gyoon (College of Pharmacy, Seoul National University) ;
- Kim, Young Joo (Department of Pharmacy, National Cancer Center)
- 발행 : 2003.12.01
초록
Filgrastim is used as an indispensable adjuvant drug to reduce the degree and duration of chemotherapy-induced neutropenia. The purpose of this research is to study the use of filgrastim by reviewing retrospective medical records of breast cancer patients who have been treated by filgtastim in the National Cancer Center. 84 patients have received 323 cycles of chemotherapy, of which 134 cycles were treated by filgrastim